Financial Summary (All financials)
| In millions, except per share items | Jan-28-23 | Jan-29-22 | Jan-30-21 | Feb-01-20 |
| Revenues | 652.5 | 428.3 | 249.9 | 0.8 |
| Revenue growth | 52.3% | 71.4% | 30450.7% | |
| Cost of goods sold | 182.7 | 124.5 | 75.4 | 0.0 |
| Gross profit | 469.9 | 303.9 | 174.5 | 0.8 |
| Gross margin | 72.0% | 70.9% | 69.8% | 99.3% |
| Sales and marketing | 370.1 | 291.2 | 202.3 | 1.1 |
| Research and development | 187.4 | 205.1 | 99.7 | |
| General and administrative | 170.8 | 159.8 | 75.2 | 1.0 |
| EBIT | -258.4 | -352.3 | -202.7 | -1.2 |
| EBIT margin | -39.6% | -82.3% | -81.1% | -150.6% |
| Pre-tax income | -243.8 | -353.9 | -210.1 | 0.0 |
| Income taxes | 3.6 | 1.2 | 0.1 | 0.0 |
| Net income | -247.4 | -355.0 | -210.2 | 0.0 |
| Net margin | -37.9% | -82.9% | -84.1% | 0.0% |
| |
| Diluted EPS | ($0.48) | ($1.28) | ($0.88) | |
| Shares outstanding (diluted) | 514.3 | 277.5 | 239.3 | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|